Home / Publications / Pain Research Forum / Papers of the Week / Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.
Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.
Diener H-C, Goadsby PJ, Ashina M, Al-Karagholi M A-M, Sinclair A, Mitsikostas D, Magis D, Pozo-Rosich P, Sieira P I, Làinez M J, Gaul C, Silver N, Hoffmann J, Marin J, Liebler E, Ferrari MD
Non-invasive vagus nerve stimulation (nVNS; gammaCore®) has the potential to prevent migraine days in patients with migraine on the basis of mechanistic rationale and pilot clinical data.
